Betaseron and Immunocomplex mediated hypersensitivity - a phase IV clinical study of FDA data

Summary:

Immunocomplex mediated hypersensitivity is reported as a side effect among people who take Betaseron (interferon beta-1b), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Provigil,.

The phase IV clinical study analyzes which people have Immunocomplex mediated hypersensitivity when taking Betaseron. It is created by eHealthMe based on reports of 26,754 people who have side effects when taking Betaseron from the FDA, and is updated regularly.

What is Betaseron?

Betaseron has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 26,886 Betaseron users. Check the latest studies of Betaseron.

What is Immunocomplex mediated hypersensitivity?

Immunocomplex mediated hypersensitivity (abnormal or pathologic immune reaction that is caused by an immune response to repeated exposure to an antigen) is found to be associated with 13 drugs and 27 conditions by eHealthMe. Check the latest studies of Immunocomplex mediated hypersensitivity.

On Jul, 10, 2026

26,754 people reported to have side effects when taking Betaseron.
Among them, 11 people (0.04%) have Immunocomplex mediated hypersensitivity.

Could Betaseron cause Immunocomplex mediated hypersensitivity?

Among these 11 people:

How long have people been on Betaseron when they have Immunocomplex mediated hypersensitivity? *

What is the gender of people who have Immunocomplex mediated hypersensitivity when taking Betaseron? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Immunocomplex mediated hypersensitivity when taking Betaseron? *

What are other drugs people take besides Betaseron? *

Vioxx: 9 people, 81.82%
Provigil: 9 people, 81.82%
Wellbutrin: 7 people, 63.64%
Prednisone: 5 people, 45.45%
Amantadine Hydrochloride: 4 people, 36.36%
Wellbutrin Sr: 2 people, 18.18%

What are other side effects people have besides Immunocomplex mediated hypersensitivity? *

Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 9 people, 81.82%
Fall: 9 people, 81.82%
Chest Pain: 9 people, 81.82%
Cuts And Puncture Wounds: 9 people, 81.82%
Difficulty In Micturition (difficulty to urinate): 9 people, 81.82%
Idiopathic Or Primary Livedo Reticularis (netlike pattern of reddish-blue skin discoloration, usually on the legs): 5 people, 45.45%
Oedema Lower Limb (fluid collection in tissue of lower leg): 5 people, 45.45%
Rash Macular (small, flat red spots): 5 people, 45.45%
Hyperreflexia (overactive or over responsive reflexes): 2 people, 18.18%
Peripheral Swelling: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Betaseron and have Immunocomplex mediated hypersensitivity?

- Check whether Immunocomplex mediated hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Betaseron:

Betaseron (26,886 reports)

Immunocomplex mediated hypersensitivity treatments and more:

Immunocomplex mediated hypersensitivity (147 reports)

How severe was Immunocomplex mediated hypersensitivity and when was it recovered:

Immunocomplex mediated hypersensitivity in Betaseron

Expand to all the drugs that have ingredients of interferon beta-1b:

Immunocomplex mediated hypersensitivity and drugs with ingredients of interferon beta-1b

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Betaseron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Immunocomplex mediated hypersensitivity:

Immunocomplex mediated hypersensitivity (13 drugs)

Browse all the conditions that are associated with Immunocomplex mediated hypersensitivity:

Immunocomplex mediated hypersensitivity (27 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on interferon beta-1b (the active ingredients of Betaseron) and Betaseron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.